These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19748378)

  • 1. [Comment on: "Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model" of S. Raffard, S. Bayard, D., Capdevielle, F. Garcia, J.-P. Boulenger et M.-C. Gely-Nargeot].
    Caillard V
    Encephale; 2009 Sep; 35(4):400-1. PubMed ID: 19748378
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing the risk for suicide in schizophrenia and affective disorders.
    Meltzer HY; Baldessarini RJ
    J Clin Psychiatry; 2003 Sep; 64(9):1122-9. PubMed ID: 14628990
    [No Abstract]   [Full Text] [Related]  

  • 3. Suicidality and Survivability in Schizophrenia.
    Naguy A; Al-Rabaie A
    J Nerv Ment Dis; 2017 Jul; 205(7):585. PubMed ID: 28657961
    [No Abstract]   [Full Text] [Related]  

  • 4. The InterSePT suicide scale for prediction of imminent suicidal behaviors.
    Ayer DW; Jayathilake K; Meltzer HY
    Psychiatry Res; 2008 Oct; 161(1):87-96. PubMed ID: 18786729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial.
    Bourgeois M; Swendsen J; Young F; Amador X; Pini S; Cassano GB; Lindenmayer JP; Hsu C; Alphs L; Meltzer HY;
    Am J Psychiatry; 2004 Aug; 161(8):1494-6. PubMed ID: 15285981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone.
    Swanson JW; Swartz MS; Elbogen EB; Van Dorn RA
    J Clin Psychiatry; 2004 Dec; 65(12):1666-73. PubMed ID: 15641872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
    Meltzer HY; Alphs L; Green AI; Altamura AC; Anand R; Bertoldi A; Bourgeois M; Chouinard G; Islam MZ; Kane J; Krishnan R; Lindenmayer JP; Potkin S;
    Arch Gen Psychiatry; 2003 Jan; 60(1):82-91. PubMed ID: 12511175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do antipsychotic medications decrease the risk of suicide in patients with schizophrenia?
    Palmer DD; Henter ID; Wyatt RJ
    J Clin Psychiatry; 1999; 60 Suppl 2():100-3; discussion 111-6. PubMed ID: 10073396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model].
    Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC
    Encephale; 2008 Dec; 34(6):597-605. PubMed ID: 19081457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors related to suicide attempts in a Tunisian sample of patients with schizophrenia].
    Bouhlel S; M'solly M; Benhawala S; Jones Y; El-Hechmi Z
    Encephale; 2013 Feb; 39(1):6-12. PubMed ID: 23095582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():41-5. PubMed ID: 9766619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients. A controlled retrospective study.
    Taiminen TJ; Kujari H
    Acta Psychiatr Scand; 1994 Oct; 90(4):247-51. PubMed ID: 7831993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia.
    Haukka J; Tiihonen J; Härkänen T; Lönnqvist J
    Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):686-96. PubMed ID: 18327869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicide attempts by jumping and psychotic illness.
    Nielssen O; Glozier N; Babidge N; Reutens S; Andrews D; Gerard A; Malhi GS; Large MM
    Aust N Z J Psychiatry; 2010 Jun; 44(6):568-73. PubMed ID: 20482416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of suicide occurring in schizophrenia (I). Risk-factors identification].
    Besnier N; Gavaudan G; Navez A; Adida M; Jollant F; Courtet P; Lançon C
    Encephale; 2009 Apr; 35(2):176-81. PubMed ID: 19393388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Suicidal behavior of schizophrenic patients in a psychiatric hospital].
    Schmölzer C; Wolfersdorf M; Hole G
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):155-69. PubMed ID: 1710390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.
    Tollefson GD; Sanger TM; Lu Y; Thieme ME
    Arch Gen Psychiatry; 1998 Mar; 55(3):250-8. PubMed ID: 9510219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current stakes in managing patients with schizophrenia].
    Kahn JP
    Encephale; 2006 Jan; 32 Pt 2():S14-5. PubMed ID: 16800081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.